The conference, “Detecting and Evaluating Drug-Induced Liver Injury; What’s Normal, What’s Not, and What Should We Do About It?", which costs $300 to $600 per ticket, will likely be attended by pharmaceutical companies, "academia, health care providers, patient groups, and regulatory bodies," according to a Federal Register notice.
FDA moves to thwart drug-induced liver problems
On Thursday, the FDA launched a campaign to educate consumers about how taking more than the recommended doses of some medication — such as acetaminophen, the active ingredient in Tylenol — can cause liver damage. The agency previously reported that drug-induced liver injury is the leading cause of acute liver failure.